Cancel
Known information
- Has a PhD in Biostatistics from the University of North Carolina at Chapel Hill
- Holds a BS in Statistics from Carnegie Mellon University
- Worked at GlaxoSmithKline supporting the oncology therapeutic area
- Led the early phase development of the cell therapy asset in both solid tumor and hematological malignancies
About Prokidney
ProKidney is a biotechnology company developing cell therapy products like REACT to transform the treatment of Chronic Kidney Disease (CKD), focusing on delaying kidney failure and reducing the need for dialysis.
Report inaccurate information
